Loading...
Nuwellis, Inc.
NUWE•NASDAQ
HealthcareMedical - Devices
$0.41
$-0.20(-33.06%)
Nuwellis, Inc. (NUWE) Financial Performance & Statements
Review Nuwellis, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-1.40%
↓ 1.40%
Operating Income Growth
37.67%
↑ 37.67%
Net Income Growth
47.43%
↑ 47.43%
Operating Cash Flow Growth
46.53%
↑ 46.53%
Operating Margin
-105.83%
↓ 105.83%
Gross Margin
63.18%
↑ 63.18%
Net Profit Margin
-112.07%
↓ 112.07%
ROE
-610.07%
↓ 610.07%
ROIC
-218.44%
↓ 218.44%
Nuwellis, Inc. (NUWE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Nuwellis, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.90M | $2.32M | $2.37M | $2.19M |
| Cost of Revenue | $837000.00 | $967000.00 | $711000.00 | $720000.00 |
| Gross Profit | $1.07M | $1.35M | $1.66M | $1.47M |
| Gross Profit Ratio | $0.56 | $0.58 | $0.70 | $0.67 |
| R&D Expenses | $550000.00 | $831000.00 | $486000.00 | $558000.00 |
| SG&A Expenses | $3.58M | $2.91M | $2.70M | $3.24M |
| Operating Expenses | $4.13M | $3.74M | $3.19M | $3.79M |
| Total Costs & Expenses | $4.96M | $4.71M | $3.90M | $4.51M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $5.61M |
| Depreciation & Amortization | $0.00 | $83000.00 | $76000.00 | $75000.00 |
| EBITDA | -$3.06M | -$1.38M | -$1.53M | -$2.04M |
| EBITDA Ratio | -$1.61 | -$0.60 | -$0.65 | -$0.93 |
| Operating Income | -$3.06M | -$2.39M | -$1.53M | -$2.32M |
| Operating Income Ratio | -$1.61 | -$1.03 | -$0.65 | -$1.06 |
| Other Income/Expenses (Net) | $47000.00 | $920000.00 | $3.89M | -$5.40M |
| Income Before Tax | -$3.01M | -$1.47M | $2.36M | -$7.72M |
| Income Before Tax Ratio | -$1.58 | -$0.63 | $1.00 | -$3.52 |
| Income Tax Expense | -$1000.00 | $1000.00 | $0.00 | $2000.00 |
| Net Income | -$3.01M | -$1.47M | $2.36M | -$7.72M |
| Net Income Ratio | -$1.58 | -$0.63 | $1.00 | -$3.52 |
| EPS | -$0.69 | -$0.44 | $1.74 | -$18.85 |
| Diluted EPS | -$0.69 | -$0.44 | $1.74 | -$18.85 |
| Weighted Avg Shares Outstanding | $4.37M | $3.37M | $1.35M | $409690.00 |
| Weighted Avg Shares Outstanding (Diluted) | $4.37M | $3.37M | $1.35M | $409690.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan